Malene Hansen, Ph.D., receives the Irving S. Wright Award of Distinction

The award, given by the Federation for Aging Research (AFAR), recognizes exceptional contributions to basic or clinical research in the field of aging.

Could low-cost leprosy drug clofazimine be repurposed for COVID-19?

Scientists pointed to clofazimine, a low-cost leprosy drug first approved by the FDA in 1986, as a possible COVID-19 drug after finding promising anti-coronavirus activity in hamsters.

Decades-Old Leprosy Drug Inhibits Coronaviruses, May Treat COVID-19

In an effort to find new treatments for COVID-19 that could be made available quickly, researchers searched through FDA-approved drugs to identify candidates that may inhibit SARS-CoV-2 replication. Researchers found that a decades-old anti-leprosy drug exhibits potent antiviral activities against many coronaviruses—including SARS-CoV-2.

In Pancreatic Cancer, New Biomarker May Predict Benefit of Tumor-Penetrating PeptideIn Pancreatic Cancer, New Biomarker May Predict Benefit of Tumor-Penetrating Peptide

In experiments with models of pancreatic cancer, a cyclic peptide called iRGD was found to penetrate tumors via a molecular pathway mediated by β5 integrin. This protein may serve as a useful biomarker, one that could indicate which patients will respond best to iRGD-combination therapy.

Evan Snyder named Fellow of the American Institute for Medical and Biological Engineering

Renowned stem cell researcher recognized by his peers for seminal contributions to regenerative medicine.